Sodium ferric gluconate
|Other names||Sodium ferric gluconate complex|
|Drug class||Iron supplement|
|Main uses||Iron deficiency anemia in people on hemodialysis who are receiving epoetin|
|Side effects||Nausea, diarrhea, dizziness, shortness of breath, chest pain, leg cramps, pain|
|Typical dose||125 mg|
|Chemical and physical data|
|Molar mass||2089.309 g·mol−1|
|3D model (JSmol)|
Sodium ferric gluconate, sold under the brand name Ferrlecit, is a medication use to treat iron deficiency anemia in people on hemodialysis who are receiving epoetin therapy. It is given by injection into a vein. In this group intravenous iron has been found to be better than iron by mouth.
Common side effects in adults include nausea, diarrhea, dizziness, shortness of breath, chest pain, leg cramps, and pain. In children the most common side effects are headache, fast heart rate, and vomiting. Other side effects may include low blood pressure and allergic reactions. It is a type of iron supplement.
It may be given as a 125 mg dose in adults or as 1.5 mg/kg in children.
- "Sodium Ferric Gluconate Monograph for Professionals". Drugs.com. Retrieved 12 October 2021.
- "Ferrlecit- sodium ferric gluconate complex injection". DailyMed. 25 September 2019. Retrieved 2 April 2020.
- "Sodium ferric gluconate complex Use During Pregnancy". Drugs.com. 16 December 2019. Retrieved 2 April 2020.
- "Ferrlecit Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 12 October 2021.
- "Intravenous iron-containing medicinal products". Retrieved 12 October 2021.
- "Sodium ferric gluconate complex". Drug Information Portal. U.S. National Library of Medicine.